NFKB1 and periodontitis: To further verify role of the NF‐κB signaling pathway in occurrence and development of periodontitis, we chose a NF‐κB signaling pathway inhibitor, BMS345541, to inhibit the NF‐κB signaling pathway, and we found that BMS345541 reversed the effects of hyperoside on the biological functions of BMSCs.